Revenue | ₹8.45Cr |
Net Profits | ₹-80.42Cr |
Net Profit Margins | -951.72% |
Sun Pharma Advanced Research Company Ltd’s revenue fell -44.04% since last year same period to ₹8.45Cr in the Q3 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 7.37% jump in its revenue since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit fell -1.14% since last year same period to ₹-80.42Cr in the Q3 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -6.03% fall in its net profits since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit margin fell -80.74% since last year same period to -951.72% in the Q3 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 1.25% jumped in its net profit margins since last 3-months.
The revenue for Sun Pharma Advanced Research Company Ltd in the Q3 results 2025 was ₹8.45Cr.
The net profit for Sun Pharma Advanced Research Company Ltd in the Q3 results 2025 was ₹-80.42Cr.
The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q3 results 2025 was -951.72%.
The revenue for Sun Pharma Advanced Research Company Ltd in the Q3 results 2024 was ₹15.10Cr.
The net profit for Sun Pharma Advanced Research Company Ltd in the Q3 results 2024 was ₹-79.51Cr.
The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q3 results 2024 was -526.56%.